McKesson planning a Florida call center

McKesson plans to lease a call center in Port St. Lucie, Fla., to support its McKesson Patient Access Solutions.

The four-year-old business offers centralized physician scheduling, physician and employee referrals, patient portal support, pre-registration and data conversion to patients on behalf of physician offices nationwide. The business currently serves 72 practices representing more than 900 doctors. The operation is currently expanding to include prescription refills services and expects to add clinician-driven case management.

McKesson currently employs approximately 300 customer service representatives in Port St. Lucie and plans to hire a number of employees over the next several months.

The new call center is scheduled to open on May 23. McKesson already has hired 31 new employees and plans to hire another 80 to 100, according to a release. Within 18 months the facility could employ as many as 700 as McKesson’s patient support business continues to grow.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.